Literature DB >> 25520069

Epidemiology, etiology, diagnosis and treatment of prostate cancer.

Muhammad Daniyal1, Zamir Ali Siddiqui, Muhammad Akram, H M Asif, Sabira Sultana, Asmatullah Khan.   

Abstract

Prostate cancer is more common in men over the age of 65 years. There are 15% cases with positive family history of prostate cancer Worldwide. Prostate cancer is the second leading cause of death among the U.S. men. Prostate cancer incidence is strongly related to age with the highest rates in older man. Globally millions of people are suffering from this disease. This study aims to provide awareness about prostate cancer as well as an updated knowledge about the epidemiology, etiology, diagnosis and treatment of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25520069     DOI: 10.7314/apjcp.2014.15.22.9575

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  37 in total

Review 1.  Conceptual review of key themes in treating prostate cancer in older adults.

Authors:  Ramy Sedhom; Arjun Gupta
Journal:  J Geriatr Oncol       Date:  2019-11-05       Impact factor: 3.599

2.  Mental Health in Urologic Oncology.

Authors:  Danyon Anderson; Abrahim N Razzak; Matthew McDonald; David Cao; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

3.  Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

Authors:  Mohammad Bagherniya; Gholamreza Askari; Babak Alikiaii; Saeed Abbasi; Davood Soleimani; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  A competing risk analysis of death patterns in male genitourinary cancer.

Authors:  Atanu Bhattacharjee; Gaurav Roy; Atul Budukh; Rajesh Dikshit; Vijay M Patil; Amit Joshi; Vanita Noronha; Kumar Prabash; Papai Roy
Journal:  Cancer Rep (Hoboken)       Date:  2019-04-04

5.  Bicalutamide enhances fodrin-mediated apoptosis through calpain in LNCaP.

Authors:  Jiyeong Lee; Sora Mun; Arum Park; Doojin Kim; Byung Heun Cha; Hee-Gyoo Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-06-03

6.  Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1.

Authors:  Lin Li; Jing Hao; Cheng-Quan Yan; He-Feng Wang; Bin Meng; Sheng-Yong Cai
Journal:  Cell Cycle       Date:  2020-10-16       Impact factor: 4.534

7.  Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis.

Authors:  Shugo Suzuki; Yukiko Mori; Aya Nagano; Aya Naiki-Ito; Hiroyuki Kato; Yuko Nagayasu; Mizuho Kobayashi; Toshiya Kuno; Satoru Takahashi
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

Review 8.  What Are the Links of Prostate Cancer with Physical Activity and Nutrition? : A Systematic Review Article.

Authors:  Joanna Kruk; Hassan Aboul-Enein
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

9.  Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients.

Authors:  Nara Yoon; Sharon Lim; So Young Kang; Ghee Young Kwon; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

10.  GIMDA: Graphlet interaction-based MiRNA-disease association prediction.

Authors:  Xing Chen; Na-Na Guan; Jian-Qiang Li; Gui-Ying Yan
Journal:  J Cell Mol Med       Date:  2017-12-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.